Celsense News - Press Releases

03-18-10
Novel Imaging Software Released by Celsense, Inc.

01-19-10
Celsense, Inc. Launches a Dual–Mode Imaging Reagent Enabling Cell Detection by MRI and Fluorescence

01-11-10
New Journal Article Offers In-Depth Analysis of Biological Impact of Celsense’s Cell Labeling Product on Human Dendritic Cells

10-19-09
Celsense, Inc Receives Funding to Develop Dual Mode Imaging Agent

10-12-09
Celsense, Inc Files FDA and EMEA Regulatory Submissions

7-2-09
Celsense, Inc Raises Additional Funds in Series B

6-2-09
Celsense, Inc Receives NIH Grant to Translate Cell Imaging Technology for Clinical Use

5-19-09
Celsense, Inc. Opens New R&D Facility

4-30-09
Celsense to Present Use of in vivo Cellular Imaging Technology with Human at International Cell Therapy Conference

4-15-09
Celsense Technologies Featured in Multiple Presentations at Upcoming Imaging Conference

4-9-09
Celsense to Present in vivo Cellular Imaging Technology at AACR as Potential Tool in Treatment of Cancer

7-23-08
Celsense, Inc. Announces New Product Release

5-2-08
Celsense, Inc. Announces Strategic Alliance with m2m Imaging

3-22-08
Celsense, Inc. Announces Sale of Series B Shares

3-22-08
Celsense, Inc. Announces Exhibit at 2008 ISMRM Conference

2-15-08
Celsense, Inc. Announces SBIR Award

10-4-07
Celsense, Inc. Announces New Product

7-22-07
Celsense, Inc. Announces First Product Sales

7-16-07
Celsense, Inc. Completes Second Series A Financing

9-14-06
Celsense, Inc. CSO Presents at Stem Cell Conference

8-14-06
Celsense, Inc. Completes $625,000 Series A Funding

12-15-05
Celsense, Inc. Completes Licensing Agreements with Carnegie Mellon University